Literature DB >> 9657040

Separation of phospholipase A2 in Habu snake venom by glycyrrhizin (GL)-affinity column chromatography and identification of a GL-sensitive enzyme.

K Ohtsuki1, Y Abe, Y Shimoyama, T Furuya, H Munakata, C Takasaki.   

Abstract

By means of glycyrrhizin (GL)-affinity and Mono S column chromatographies (HPLC), at least four GL-binding proteins (p25, p17, p15-1 and p15-2) in the two Superdex fractions (P-II and P-III fractions) from Habu snake venom were selectively purified. By determination of their N-terminal partial amino acid sequences, a metalloprotease (p25) and three GL-binding phospholipases A2 (gbPLA2s) [PA2Y (p17), PA21 (p15-1) and PA2B (p15-2)] were identified. PA2B (lysine-49 PLA2) was found to be the most sensitive to GL because (i) it strongly bound to a GL-affinity column; and (ii) its enzyme activity was selectively inhibited by low dose (ID50 = approx. 1.5 microM) of GL, but not by GA. Furthermore, these three gbPLA2s were phosphorylated by casein kinase II (CK-II) in vitro and GL inhibited the CK-II-mediated stimulation of their enzyme activities in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657040     DOI: 10.1248/bpb.21.574

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.

Authors:  M P Manns; H Wedemeyer; A Singer; N Khomutjanskaja; H P Dienes; T Roskams; R Goldin; U Hehnke; H Inoue
Journal:  J Viral Hepat       Date:  2012-02-24       Impact factor: 3.728

2.  The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain.

Authors:  Seung-Woo Kim; Chae-Moon Lim; Hye-Kyung Lee; Ja-Kyeong Lee
Journal:  Anat Cell Biol       Date:  2011-12-30

3.  Hepatoprotective triterpene saponins from the roots of Glycyrrhiza inflata.

Authors:  Yun-Feng Zheng; Juan-Hua Wei; Shi-Qi Fang; Yu-Ping Tang; Hai-Bo Cheng; Tian-Lin Wang; Cun-Yu Li; Guo-Ping Peng
Journal:  Molecules       Date:  2015-04-09       Impact factor: 4.411

Review 4.  Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.

Authors:  Seidu A Richard
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

5.  Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.

Authors:  Yoshihiro Matsumoto; Tomokazu Matsuura; Haruyo Aoyagi; Mami Matsuda; Su Su Hmwe; Tomoko Date; Noriyuki Watanabe; Koichi Watashi; Ryosuke Suzuki; Shizuko Ichinose; Kenjiro Wake; Tetsuro Suzuki; Tatsuo Miyamura; Takaji Wakita; Hideki Aizaki
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

6.  Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day treatment assignment clinical trial.

Authors:  Youichi Yanagawa; Masatsune Ogura; Eita Fujimoto; Satoshi Shono; Eriya Okuda
Journal:  Curr Ther Res Clin Exp       Date:  2004-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.